EURO-ECOLE: Assessment of the Bioavailability and Potential Ecological Effects of Copper in European Surface Waters ; subproject 4: Evaluation and improvement of the ecological relevance of laboratory generated toxicity data

This report summarizes the acute and chronic toxicity of copper to algae, Daphnia and a few other freshwater species in standard laboratory test water and a wide range of natural surface waters (collected across Europe), with a wide range of pH, dissolved organic carbon (DOC) concentration and hardness. These data can be used for validation of bioavailability models such as the biotic ligand model (BLM)

The clinical heterogeneity of drug-induced myoclonus: an illustrated review

Contains fulltext : 177995.pdf (publisher's version ) (Open Access)A wide variety of drugs can cause myoclonus. To illustrate this, we first discuss two personally observed cases, one presenting with generalized, but facial-predominant, myoclonus that was induced by amantadine; and the other presenting with propriospinal myoclonus triggered by an antibiotic. We then review the literature on drugs that may cause myoclonus, extracting the corresponding clinical phenotype and suggested underlying pathophysiology. The most frequently reported classes of drugs causing myoclonus include opiates, antidepressants, antipsychotics, and antibiotics. The distribution of myoclonus ranges from focal to generalized, even amongst patients using the same drug, which suggests various neuro-anatomical generators. Possible underlying pathophysiological alterations involve serotonin, dopamine, GABA, and glutamate-related processes at various levels of the neuraxis. The high number of cases of drug-induced myoclonus, together with their reported heterogeneous clinical characteristics, underscores the importance of considering drugs as a possible cause of myoclonus, regardless of its clinical characteristics